213 related articles for article (PubMed ID: 9444410)
1. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.
Kamberi P; Atsuro H; Takayoshi T; Masaru N
Chemotherapy; 1998; 44(1):55-62. PubMed ID: 9444410
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Trichosporon beigelii to antifungal agents.
Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M
J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185
[TBL] [Abstract][Full Text] [Related]
3. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
Tokimatsu I; Kushima H; Hashinaga K; Umeki K; Ohama M; Ishii H; Kishi K; Hiramatsu K; Kadota J
Int J Antimicrob Agents; 2007 Jan; 29(1):84-8. PubMed ID: 17189098
[TBL] [Abstract][Full Text] [Related]
4. Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.
Walsh TJ; Peter J; McGough DA; Fothergill AW; Rinaldi MG; Pizzo PA
Antimicrob Agents Chemother; 1995 Jun; 39(6):1361-4. PubMed ID: 7574531
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.
Anaissie EJ; Hachem R; Karyotakis NC; Gokaslan A; Dignani MC; Stephens LC; Tin-U CK
Antimicrob Agents Chemother; 1994 Nov; 38(11):2541-4. PubMed ID: 7872744
[TBL] [Abstract][Full Text] [Related]
6. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
Anaissie E; Gokaslan A; Hachem R; Rubin R; Griffin G; Robinson R; Sobel J; Bodey G
Clin Infect Dis; 1992 Nov; 15(5):781-7. PubMed ID: 1445976
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
Sanati H; Ramos CF; Bayer AS; Ghannoum MA
Antimicrob Agents Chemother; 1997 Jun; 41(6):1345-8. PubMed ID: 9174196
[TBL] [Abstract][Full Text] [Related]
8. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
9. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis.
Warn PA; Sharp A; Morrissey G; Denning DW
J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of recombinant human granulocyte-colony stimulating factor alone and in combination with antifungal agents against disseminated trichosporonosis in neutropenic mice.
Perparim K; Hashimoto A; Nasu M
J Infect Chemother; 1996; 2(4):232-239. PubMed ID: 29681373
[TBL] [Abstract][Full Text] [Related]
11. Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents.
Yamamoto K; Makimura K; Sudo T; Shibuya K; Uchida K; Yamaguchi H
J Med Vet Mycol; 1997; 35(6):411-8. PubMed ID: 9467108
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis.
Treviño-Rangel Rde J; López LJ; Palma-Nicolás JP; Hernández-Bello R; González JG; González GM
J Antimicrob Chemother; 2014 Apr; 69(4):1075-8. PubMed ID: 24252752
[TBL] [Abstract][Full Text] [Related]
13. Post-antibiotic effect and post-expositional polyene antagonism of azole antifungal agents in Candida albicans: dependence on substance lipophilia.
Scheven M; Scheven C; Hahn K; Senf A
Mycoses; 1995; 38(11-12):435-42. PubMed ID: 8720192
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal susceptibilities of Trichosporon species.
Paphitou NI; Ostrosky-Zeichner L; Paetznick VL; Rodriguez JR; Chen E; Rex JH
Antimicrob Agents Chemother; 2002 Apr; 46(4):1144-6. PubMed ID: 11897610
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis.
Serena C; Pastor FJ; Gilgado F; Mayayo E; Guarro J
Antimicrob Agents Chemother; 2005 Feb; 49(2):497-502. PubMed ID: 15673724
[TBL] [Abstract][Full Text] [Related]
19. Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
Gumbo T; Drusano GL; Liu W; Ma L; Deziel MR; Drusano MF; Louie A
Antimicrob Agents Chemother; 2006 Nov; 50(11):3695-700. PubMed ID: 16954319
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
Myoken Y; Sugata T; Myoken Y; Kyo T; Fujihara M; Mikami Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Feb; 87(2):174-9. PubMed ID: 10052372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
